Invion Limited confirmed that Chief Operating Officer, Craig Newton will commence in the role of Chief Executive Officer effective 1 November 2019. Mr. Newton joined Invion as Chief Operating Officer in April 2018. He has over 30 years of experience in senior business and operational roles gained at various leading global companies including CSL, Serono UK, Bio Nova International, AVAX Australia and Cryptome Pharmaceuticals.

Dr. Greg Collier will retire as MD and CEO, effective 31 October 2019. Dr. Collier will remain on the Board of Invion as a Non-Executive Director.